Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
美普珠单抗在健康志愿者和 COVID-19 患者中的安全性和有效性：一项随机 1 期试验和一项探索性 2 期试验
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-021-00603-6
Bian, Huijie; Zheng, Zhao-Hui; Wei, Ding; Wen, Aidong; Zhang, Zheng; Lian, Jian-Qi; Kang, Wen-Zhen; Hao, Chun-Qiu; Wang, Jing; Xie, Rong-Hua; Dong, Ke; Xia, Jie-Lai; Miao, Jin-Lin; Kang, Wen; Li, Guoquan; Zhang, Di; Zhang, Mingru; Sun, Xiu-Xuan; Ding, Likun; Zhang, Kui; Jia, Junfeng; Ding, Jin; Li, Zhiqin; Jia, Yanyan; Liu, Lin-Na; Zhang, Zhe; Gao, Zhao-Wei; Du, Hong; Yao, Na; Wang, Qing; Wang, Ke; Geng, Jie-Jie; Wang, Bin; Guo, Ting; Chen, Ruo; Zhu, Yu-Meng; Wang, Li-Juan; He, Qian; Yao, Rui-Rui; Shi, Ying; Yang, Xiang-Min; Zhou, Jian-Sheng; Ma, Yi-Nan; Wang, Ya-Tao; Liang, Xue; Huo, Fei; Wang, Zhe; Zhang, Yang; Yang, Xu; Zhang, Ye; Gao, Lu-Hua; Wang, Ling; Chen, Xiao-Chun; Tang, Hao; Liu, Shuang-Shuang; Wang, Qing-Yi; Chen, Zhi-Nan; Zhu, Ping
